Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AT132
AT132
Astellas Sees Path Forward for Gene Therapy Despite Four Patient Deaths
BioSpace
Thu, 11/16/23 - 11:36 am
Astellas
AT132
patient deaths
FDA
X-linked myotubular myopathy
Astellas reports fourth death in halted gene therapy trial
Pharmaforum
Tue, 09/14/21 - 10:59 am
Astellas
gene therapy
AT132
patient deaths
clinical trials
X-linked myotubular myopathy
More trouble for Astellas as AT132 gene therapy trial is halted again
Pharmaforum
Wed, 09/1/21 - 11:02 am
Astellas
gene therapy
AT132
clinical trials
X-linked myotubular myopathy
Astellas takes $540M impairment charge over Audentes' gene therapy trial hold
Fierce Biotech
Tue, 04/27/21 - 10:47 am
Astellas
Audentes
AT132
gene therapy
Audentes sees FDA hold lifted after 3 trial deaths blighted $3B program
Fierce Biotech
Mon, 12/28/20 - 10:59 am
Audentes
Astellas
FDA
clinical trials
AT132
gene therapy
X-linked myotubular myopathy
Astellas' Audentes reports 3rd death in gene therapy trial
Fierce Biotech
Fri, 08/21/20 - 12:11 pm
Audentes Therapeutics
Astellas
clinical trials
gene therapy
patient deaths
AT132
Two patients die in now-halted study of Audentes gene therapy
BioPharma Dive
Sat, 06/27/20 - 11:35 pm
Audentes Therapeutics
gene therapy
patient deaths
clinical trials
AT132
myotubular myopathy